Selection of the candidate compound at an early stage of new drug development: retrospective pharmacokinetic and metabolic evaluations of valsartan using common marmosets-Reference-Cited by-同舟云学术

Selection of the candidate compound at an early stage of new drug development: retrospective pharmacokinetic and metabolic evaluations of valsartan using common marmosets

Published:2022-06-03 Issue:6 Volume:52 Page:613-624
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Matsumoto Shogo¹^ORCID,Uehara Shotaro²^ORCID,Kamimura Hidetaka²³^ORCID,Cho Naoki¹^ORCID,Ikeda Hiroshi⁴,Maeda Satoshi⁵,Kagiyama Kensuke⁵,Miyata Atsunori¹,Suemizu Hiroshi²^ORCID,Fukasawa Kazumasa⁵

Affiliation:

1. Drug and Discovery and Management Department, R and D Division, Meiji Seika Pharma Co., Ltd, Tokyo, Japan

2. Department of Applied Research for Laboratory Animals, Central Institute for Experimental Animals, Kawasaki, Japan

3. Business Promotion Department, CLEA Japan, Inc, Tokyo, Japan

4. Tokyo Animal and Diet Department, CLEA Japan, Inc, Tokyo, Japan

5. Yaotsu Breeding Center, CLEA Japan, Inc, Gifu, Japan

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00498254.2022.2127131

Reference60 articles.

1. Pharmacokinetics of Eprosartan in Healthy Subjects, Patients with Hypertension, and Special Populations

2. Valsartan: Preclinical and Clinical Profile of an Antihypertensive Angiotensin-II Antagonist

3. A Perspective on the Prediction of Drug Pharmacokinetics and Disposition in Drug Research and Development

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of human serum concentration–time profiles of therapeutic monoclonal antibodies using common marmosets ( Callithrix jacchus ): initial assessment with canakinumab, adalimumab, and bevacizumab;Xenobiotica;2024-07-26